DA-3002

DRUG3 trials

Sponsors

Dong-A ST Co., Ltd.

Conditions

Idiopathic Short StatureInfant, Small for Gestational AgeTurner's Syndrome

Phase 3

Efficacy and Safety of DA-3002 in Children With Idiopathic Short Stature

CompletedNCT01786902

Dong-A ST Co., Ltd.Idiopathic Short Stature

Start: 2012-02-29End: 2014-04-30Updated: 2017-10-19

A Clinical Study to Assess the Efficacy and Safety of DA-3002

CompletedNCT01813630

Dong-A ST Co., Ltd.Turner's Syndrome

Start: 2013-02-28End: 2018-05-31Updated: 2018-07-26

Efficacy and Safety of DA-3002 in Short Children Borns SGA.

CompletedNCT02770157

Dong-A ST Co., Ltd.Infant, Small for Gestational Age

Start: 2016-02-26End: 2019-08-28Updated: 2019-10-16

Related Papers

Recombinant growth hormone therapy in children with Turner Syndrome in Korea: a phase III Randomized Trial.

2021-12-104 citations

Efficacy and safety of the recombinant human growth hormone in short children born small for gestational age

Medicine2021-07-303 citations